massarray sars cov 2 variant panel v3 ruo (agena bioscience)
agena bioscience is a verified supplier 
agena bioscience manufactures this product 
97
Structured Review
agena bioscience
massarray sars cov 2 variant panel v3 ruo
Massarray Sars Cov 2 Variant Panel V3 Ruo, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+system+agena+bioscience/MassARRAY+SARS-CoV-2+Variant+Panel+Set/pm36611325-60-43-50
Average 97 stars, based on 25 article reviews
Massarray Sars Cov 2 Variant Panel V3 Ruo, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+system+agena+bioscience/MassARRAY+SARS-CoV-2+Variant+Panel+Set/pm36611325-60-43-50
Average 97 stars, based on 25 article reviews
massarray sars cov 2 variant panel v3 ruo - by Bioz Stars,
2026-10
97/100 stars
Images
1) Product Images from "Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests."
Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests.
Journal: Diagnostics (Basel, Switzerland)
doi: 10.3390/diagnostics13010034
Figure Legend Snippet: Figure 2. Regression analysis of the Xpert® Xpress SARS-CoV-2, Xpert® Xpress CoV-2 plus and Xpert® Xpress CoV-2/Flu/RSV tests, including the equation of the line and R2 values. (a) Xpert®
Techniques Used:
Related Articles
Mutagenesis:Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests. Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or Variant Assay:Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests. Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants Article Snippet: .. We recovered residual viral RNA from all 391 specimens from −80°C storage to undergo testing on the Agena Article Title: A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants Article Snippet: .. We recovered residual viral RNA from all 391 specimens from −80°C storage to undergo testing on the Agena Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or Article Title: A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants Article Snippet: .. Agena Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants Article Snippet: .. We assessed the diagnostic performance of the highly multiplexed Agena Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants Article Snippet: .. These specimens had previously undergone WGS for epidemiologic surveillance, and we used this data as a benchmark to evaluate the diagnostic performance of the Agena Next-Generation Sequencing:Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests. Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or Whole Complete genome sequencing:Article Title: A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants Article Snippet: .. Agena Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants Article Snippet: .. These specimens had previously undergone WGS for epidemiologic surveillance, and we used this data as a benchmark to evaluate the diagnostic performance of the Agena Diagnostic Assay:Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants Article Snippet: .. We assessed the diagnostic performance of the highly multiplexed Agena Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants Article Snippet: .. These specimens had previously undergone WGS for epidemiologic surveillance, and we used this data as a benchmark to evaluate the diagnostic performance of the Agena |